Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Engineering and Physical Sciences Research Council (EPSRC) has funded a new Centre for Doctoral Training (CDT) in Health Data Science at the University of Oxford. The Centre will be located within the Big Data Institute, and will play a leading role in training the next generation of health data scientists.

The training programme will be led by the University’s Department of Computer Science, with strong engagement from the Departments of Statistics, Engineering Science, Medicine, and Population Health, together with the Wellcome Centre for Ethics and Humanities (WEH).  The students will be able to work with a wide range of partner organisations, including: Oxford University Hospitals NHS Trust, Microsoft, IBM, NVIDIA, McLaren, Celgene, Sensyne Health, GSK, Vertex Pharmaceuticals, Insilico Medicine, Elsevier, Zegami, UCB, Perspectum, the CRUK Oxford Cancer Centre, University College Blockchain Centre, MedaPhor, and the Li Ka Shing Foundation.

Read more (Big Data Institute website)

Similar stories

Parental mental health worsens under new national COVID-19 restrictions

Coronavirus COVID-19 General Research

Parental stress, depression and anxiety have again increased since new national restrictions have been introduced, according to the latest report from the Oxford University-led COVID-19 Supporting Parents, Adolescents, and Children in Epidemics (Co-SPACE) study, based on data from over 6000 UK parents.

£100 million donation from Ineos to create new institute to fight antimicrobial resistance

Awards and Appointments General Innovation

A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from Ineos.

RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19

Clinical Trials Coronavirus COVID-19 General Research

The RECOVERY trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19.

Ancient gene mutation found to cause rare hereditary condition

General Research

UK scientists have found that a 7,000-year-old genetic mutation is responsible for a rare form of hereditary motor neuropathy (HMN).

National consortium to study threats of new SARS-CoV-2 variants

Coronavirus COVID-19 General Research

A new national research project to study the effects of emerging mutations in SARS-CoV-2 will be launched with £2.5 million funding from UK Research and Innovation (UKRI).